Research Articles
The Bacterial Warrior: How a Tiny Microbe Could Revolutionize Cancer Treatment
Discover how Lactiplantibacillus plantarum L125, a probiotic strain, shows promising anti-cancer properties through genomic analysis and experimental studies.
The Kefir Cure: How a Tangy Probiotic Could Help Fight Cancer
Discover how scientists are using water and milk kefir to produce L-Asparaginase, a potential cancer-fighting enzyme, in this groundbreaking research.
Green Tea's Secret Weapon: How EGCG Targets Cancer at the Molecular Level
Discover how EGCG from green tea inhibits HER-2/neu activation and downstream signaling pathways in cancer cells, offering promising therapeutic potential.
Taming a Vampire Cell: The Chemotherapy That Fought a Rare Cancer
Discover how HCVAD chemotherapy transformed treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), a rare and aggressive blood cancer.
The Hidden Switches in Our DNA: How a Tiny Genetic Variation Could Fuel Cancer
Discover how tiny genetic variations called SNPs in 3′ UTR regions can hijack cellular machinery and potentially drive cancer development through STAT1 gene regulation.
Chromosomal Instability: The Genetic Chaos Fueling Smarter Cancers
Explore how chromosomal instability drives cancer evolution, recent discoveries linking CIN to epigenetic changes, and promising therapeutic strategies targeting this genetic chaos.
The Hidden Biological Clues: How Opium Use Increases Cancer Risk
Discover how opium use creates distinct biological signatures that increase cancer risk through IL-33/sST2 imbalance and adiponectin receptor changes.
Unleashing the Assassin: How Scientists Are Re-Arming the Body's Immune System to Attack Cancer
Discover how immune checkpoint blockers are revolutionizing the treatment of leukemia and lymphoma by re-arming the body's own T-cells to fight cancer.
Silencing the Signal: How Blocking CCL18 Could Revolutionize Fibrosis and Cancer Treatment
Exploring the role of CCL18/CCR6 axis in fibrosis and cancer progression, and how blocking this signaling pathway could lead to new treatments.
The ERBB3 Enigma: How a "Weak" Receptor Dictates Cancer's Response to Treatment
Exploring the paradoxical role of ERBB3 (HER3) in cancer biology and its context-dependent effects on treatment response.